Category Archives: For Ophthalmologists

Make the Difference: Preventing Medical Trainee Suicide
Oct 30th, 2018

Access Details Learn more about the American Foundation for Suicide Prevention and their initiatives.

Programme de rétroaction personnalisée sur la pratique (PRPP)
Oct 29th, 2018

The Programme de rétroaction personnalisée sur la pratique (PRPP) is an in-depth online assessment tool that allows Québec medical specialists to obtain feedback on their practice. The voluntary assessment was developed by the Fédération des médecins spécialistes du Québec (FMSQ). The PRPP proposes three questionnaires aimed at the colleagues and patients of each physician. You may […]

Prescribing Safely Canada Accredited Modules
Oct 29th, 2018

Building on the success of Prescribing Safely Canada pilot and the feedback, the Royal College is pleased to offer accredited modules that offer more prescribing assessments across specialties in a new engaging format. For a limited time only, please take advantage of this accredited learning opportunity to assess your prescribing skills. Target Audience These online […]

Medical use of cannabis for glaucoma
Oct 26th, 2018

October 2018 Background The clinical utility of cannabis (sometimes referred to as marijuana or marihuana) for the treatment of glaucoma is limited by the inability to separate the potential clinical action from the undesirable neuropsychological and behavioural effects. The Canadian Ophthalmological Society does not support the medical use of cannabis for the treatment of glaucoma […]

Micro-invasive or minimally invasive glaucoma surgery (2017)
Oct 26th, 2018

Position Statement (December 2017) Summary Current surgical treatments for glaucoma are aimed at reducing intraocular pressure (IOP) through decreasing aqueous inflow or enhancing of aqueous outflow and thereby reducing the risk of visual field loss. While trabeculectomy and implantation of glaucoma drainage devices are the standard and more commonly performed surgical interventions for glaucoma, they […]

Effects of electronic screens on children’s vision and recommendations for safe use
Oct 26th, 2018

(2017) Joint Position Statement Read the full position statement from the Canadian Association of Optometrists (CAO) and the Canadian Ophthalmological Society (COS).

Cuban treatment for retinitis pigmentosa
Oct 26th, 2018

Position Statement November 2016 Summary Retinitis Pigmentosa (RP) is part of a group of rare genetic disorders that cause slow but progressive degeneration of photoreceptor cells in the retina. RP symptoms typically begin in childhood with decreased night vision, followed by loss of peripheral vision, and can eventually lead to complete loss of vision. There […]

Valuation of uninsured ophthalmological services
Oct 26th, 2018

Report 2016 Read the full report on the valuation of uninsured ophthalmological services Canadian ophthalmologists asked the Canadian Ophthalmological Society (COS) to provide guidance with regard to physician fees for services that are presently uninsured by provincial and territorial health insurance in many jurisdictions. COS commissioned Health Intelligence Inc., an independent and well-respected health research […]

Guidelines for refractive surgery advertising
Oct 26th, 2018

Reviewed August 2022 The Canadian Ophthalmological Society (COS) and its subspecialty society, the Canadian Cornea, External Disease & Refractive Surgery Society (CCEDRSS), are committed to excellence in ophthalmology. Excellence requires adherence to the highest ethical standards in all professional activities, including marketing and advertising. Our guiding principle is that the welfare of the patient is […]